695 participants
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2025-04-04
- Completion:
- 2029-10-31
Conditions
- Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Interventions
- DRUG
No Results Yet